Opioid epidemic
US Supreme Court halts Purdue Pharma $6bn bankruptcy settlement
The company has been blamed for fuelling the opioid crisis by promoting its drug OxyContin
US Supreme Court asked to block Purdue Pharma bankruptcy settlement
The company has been blamed for fuelling the opioid crisis with the promotion of its drug OxyContin
Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit
For pursuing the case, the former employee will receive about $250m
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
The Sackler family will pay the amount over 18 years to victims of addiction and US states
Purdue to pay over $8bn to settle opioid-related criminal claims
Claims relate to Purdue's involvement in fuelling the opioid addiction crisis
Mallinckrodt files for bankruptcy protection in the US
Bankruptcy filing will reduce debts related to legal liabilities
US charges Teva for generic drug price-fixing plot
Company maintains it has not committed any wrongdoing
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
Company faces new accusations of dishonest marketing tactics
Mallinckrodt reaches tentative $1.6bn opioid settlement
Agreement reached with a plaintiff's executive committee
FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
Verdict closely follows rejection of Nektar’s opioid analgesic
Nektar’s opioid analgesic slammed with FDA panel rejection
Panelists unanimously rejected use of the chronic back pain drug
J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial
Cites misuse of public nuisance laws as grounds for appeal